Background
Spontaneous HIV controllers suppress viremia without antiretroviral therapy, yet many eventually lose control. The mechanisms that sustain long‐term suppression remain unclear. IL-32, an intracellular cytokine that influences both antiviral defences and immune regulation, has been implicated in HIV pathogenesis and the transition from control to progression. We hypothesize that host genetic and non-genetic factors regulating IL-32 expression may influence the responses leading to the persistence of spontaneous HIV control.
Methods
IL32 expression was assessed on bulk PBMCs RNA-seq from the 2000HIV study (NCT03994835), including 1,774 PLHIV: 57 persistent controllers (who maintained HIV control), 57 transient controllers (who subsequently lost HIV control), and 1,664 normal progressors. SNPs within the IL32 locus (chr16:3,055,000–3,085,000) were associated with gene expression (eQTL) and with cytokine production from PBMCs upon stimulation with bacterial and viral ligands (cytokineQTL). These associations were identified in Discovery (n=1,048) and Validation (n=260) cohorts using MatrixEQTL with inverse-rank transformed traits. Single-cell RNA-seq in 280 PLHIV was analyzed across major circulating immune cell subsets.
Results
In PBMCs, IL32 expression was higher IL32 PLHIV of African ancestry. Persistent controllers trended to higher IL32 in comparison to transient controllers (p=0.056) and normal progressors (p=0.052). eQTL mapping identified eight SNPs that regulates IL32 expression in PBMCs, including rs1064948 (pdisc=0.00019, pval=0.0018); Functionally, rs1064948 correlated with differential expression of immune genes (e.g., IL1B) and with IL-6 production after 24h LPS (pdisc=0.045, pval=0.0016). Six additional SNPs in the locus were linked to cytokine QTLs, including responses towards HIV-Env (IL1-RA, pdisc=0.019, pval=0.044) and CMV-pp65 (IL-8, pdisc=0.044, pval=0.011). scRNA-seq identified NK cells, CD4, and CD8 T cells as the main IL32-producing cell types, with higher expression in persistent compared to transient controllers (p=3.97×10-38, p=2.85×10-132, p=1.09×10-87, respectively).
Conclusions
In PLHIV, IL32 expression is shaped by ancestry and genetic variation and is primarily restricted to NK and T cells in persistent controllers. Elevated IL32 expression, together with enhanced cytokines against microbial-derived ligands, may sustain the responses associated with HIV control.